Selvita S.A. (SLV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Selvita S.A. (SLV) has a cash flow conversion efficiency ratio of 0.020x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł6.47 Million ≈ $1.78 Million USD) by net assets (zł317.10 Million ≈ $87.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Selvita S.A. stock valuation for the company's overall valuation and market capitalisation.
Selvita S.A. - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Selvita S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Selvita S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Selvita S.A. ranked by their cash flow conversion efficiency. Explore earnings quality score of Selvita S.A. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eastech Holding Limited
TW:5225
|
0.058x |
|
Graphene Manufacturing Group Ltd
V:GMG
|
-0.208x |
|
Finance of America Companies Inc
NYSE:FOA
|
0.000x |
|
Capral Ltd
AU:CAA
|
0.152x |
|
OHTL Public Company Limited
BK:OHTL
|
0.031x |
|
Alldigi Tech Limited
NSE:ALLDIGI
|
0.129x |
|
O-TA Precision Industry Co Ltd
TWO:8924
|
0.031x |
|
Forrester Research Inc
NASDAQ:FORR
|
-0.030x |
Annual Cash Flow Conversion Efficiency for Selvita S.A. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Selvita S.A. from 2015 to 2025. View SLV stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł321.73 Million ≈ $88.54 Million |
zł64.32 Million ≈ $17.70 Million |
0.200x | +0.44% |
| 2024-12-31 | zł321.88 Million ≈ $88.59 Million |
zł64.07 Million ≈ $17.63 Million |
0.199x | -17.57% |
| 2023-12-31 | zł327.07 Million ≈ $90.01 Million |
zł78.98 Million ≈ $21.74 Million |
0.241x | -12.55% |
| 2022-12-31 | zł273.16 Million ≈ $75.18 Million |
zł75.43 Million ≈ $20.76 Million |
0.276x | -35.11% |
| 2021-12-31 | zł205.55 Million ≈ $56.57 Million |
zł87.47 Million ≈ $24.07 Million |
0.426x | +121.29% |
| 2020-12-31 | zł152.66 Million ≈ $42.01 Million |
zł29.36 Million ≈ $8.08 Million |
0.192x | +113.17% |
| 2019-12-31 | zł47.66 Million ≈ $13.12 Million |
zł4.30 Million ≈ $1.18 Million |
0.090x | -61.73% |
| 2018-12-31 | zł49.19 Million ≈ $13.54 Million |
zł11.60 Million ≈ $3.19 Million |
0.236x | -16.47% |
| 2017-12-31 | zł37.34 Million ≈ $10.28 Million |
zł10.54 Million ≈ $2.90 Million |
0.282x | +350.36% |
| 2016-12-31 | zł55.71 Million ≈ $15.33 Million |
zł-6.28 Million ≈ $-1.73 Million |
-0.113x | +67.84% |
| 2015-12-31 | zł46.88 Million ≈ $12.90 Million |
zł-16.43 Million ≈ $-4.52 Million |
-0.350x | -- |
About Selvita S.A.
Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libr… Read more